[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345345-105":59,"doc-detail-345345-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-mechanistic-study-revealing-that-slco1b3-promotes-gastric-cancer-development-and-metastasis-through-map1s-expression-downregulation","A mechanistic study revealing that SLCO1B3 promotes gastric cancer development and metastasis through MAP1S expression downregulation","","Gastric cancer remains a leading cause of cancer-related mortality worldwide, and understanding its molecular pathogenesis is essential for new therapeutic development. This study uses clinical sample sequencing and immunohistochemistry to map SLCO1B3 expression in gastric tumors and adjacent normal tissues and evaluates its association with prognosis. In vitro gain- and loss-of-function experiments test effects on proliferation, migration, and invasion, while in vivo overexpression assesses tumorigenesis. RNA sequencing identifies MAP1S as a downstream candidate and supports SLCO1B3-driven progression via MAP1S downregulation. SLCO1B3 is elevated in cancer and linked to poorer survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-mechanistic-study-revealing-that-slco1b3-promotes-gastric-cancer-development-and-metastasis-through-map1s-expression-downregulation/345345/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-mechanistic-study-revealing-that-slco1b3-promotes-gastric-cancer-development-and-metastasis-through-map1s-expression-downregulation/345345.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study?","Question",{"text":112,"@type":113},"The study investigates how SLCO1B3 promotes gastric cancer development and metastasis, with attention to downstream regulation involving MAP1S expression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is SLCO1B3 expression assessed in patients and tissues?",{"text":117,"@type":113},"Clinical sample sequencing and immunohistochemical analyses are used to determine SLCO1B3 expression patterns in gastric cancer tissues and surrounding normal tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence links SLCO1B3 to tumor behavior?",{"text":121,"@type":113},"In vitro experiments test SLCO1B3 overexpression and knockdown effects on gastric cancer cell proliferation, migration, and invasion, and in vivo overexpression studies evaluate carcinogenesis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345345,1791476259,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Liang et al. BMC Cancer (2026) 26:593 [https://doi.org/10.1186/s12885-026-15917-3](https://doi.org/10.1186/s12885-026-15917-3)  \nBMC Cancer  \nRESEARCH Open Access  \nA mechanistic study revealing that SLCO1B3 promotes gastric cancer development and metastasis through MAP1S expression downregulation  \nShihao Liang1,2†, Yangyuan Huang1,2†, Liping Li1,2†, Qingyu Zeng1,2, Wenjie Liao1,2, Weiyan Li1,2, Leiyu Qin1,2 and Bin Li 1,2*  \nAbstract  \nBackground Gastric cancer (GC) remains a significant cause of mortality worldwide. Exploring the pathogenesis of GC is crucial for developing new therapeutic strategies.  \nMethods Clinical sample sequencing and immunohistochemical analyses were employed to investigate the expression patterns of solute carrier organic anion transporter B3 (SLCO1B3) in GC and surrounding normal tissues, as well as its effect on GC prognosis. In vitro GC studies were performed to confirm the effects of SLCO1B3 overexpression and knockdown on GC cell proliferation, migration, and invasion, as well as the influence of SLCO1B3 overexpression on carcinogenesis in vivo. Furthermore, RNA sequencing of gastric cancer cells overexpressing SLCO1B3 revealed microtubule-associated protein 1 S (MAP1S) as a potential downstream target, suggesting SLCO1B3 may promote gastric cancer progression by regulating MAP1S expression.  \nConclusion SLCO1B3 expression is elevated in GC versus adjacent tissues and correlates with diminished patient survival rates. Overexpression of Ct-SLCO1B3 may be associated with downregulation of MAP1S, suggesting that Ct-SLCO1B3 may promote gastric cancer development and metastasis by regulating its expression.  \nKeywords Gastric cancer, SLCO1B3, Tumorigenesis, metastasis, MAP1S  \n†Shihao Liang, Yangyuan Huang and Liping Li contributed equally to this work and are co-first authors.  \n*Correspondence: Bin Li [leebien@163.com](leebien@163.com)  \n1Department of Gastroenterology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, People’s Republic of China  \n2Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Affliated Hospital of Guilin Medical University, Guilin, Guangxi, People’s Republic of China  \nIntroduction  \nGastric cancer (GC) remains one of the most common malignant tumors worldwide and is a major cause of death [1]. Gastrointestinal tumors account for 23.9% of all new cancer cases and 33.2% of cancer-related deaths globally [2]. In China, the incidence and mortality rates of gastrointestinal tumors remain high [3]. Traditionally, the primary treatment for GC has been surgery, with molecular targeted therapy as an adjunct. Recently, significant progress has been made in the treatment of GC through molecular targeted therapy and immunotherapy. Therefore, in-depth explorations ofthe mechanisms underlying  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLiang et al. BMC Cancer (2026)","cbCaich5c0KRk9qa","https://ap.wps.com/l/cbCaich5c0KRk9qa","pdf",3189693,16,"English","# Abstract\n# Background\n# Methods\n# Conclusion\n# Keywords\n# Introduction\n## Gastric cancer burden and treatment context\n## Solute carrier transporters and SLCO1B3\n## MAP1S functions and relevance to cancer","[{\"question\":\"What is the main focus of the study?\",\"answer\":\"The study investigates how SLCO1B3 promotes gastric cancer development and metastasis, with attention to downstream regulation involving MAP1S expression.\"},{\"question\":\"How is SLCO1B3 expression assessed in patients and tissues?\",\"answer\":\"Clinical sample sequencing and immunohistochemical analyses are used to determine SLCO1B3 expression patterns in gastric cancer tissues and surrounding normal tissues.\"},{\"question\":\"What evidence links SLCO1B3 to tumor behavior?\",\"answer\":\"In vitro experiments test SLCO1B3 overexpression and knockdown effects on gastric cancer cell proliferation, migration, and invasion, and in vivo overexpression studies evaluate carcinogenesis.\"}]","A mechanistic study revealing that SLCO1B3 promotes gastric cancer development and metastasis through MAP1S expression downregulation | PDF",1790057375,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/503ac80d6a080e60cc752d7f8c5cf963.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e39fabdda78a260cca573af1da7d0b42.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c0a9037c40faeeee59742e1a747d51a.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b05a4c6e13cb367b7406d763b50f27cf.webp",980,1306]